You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

VMT02

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma (Skin), Melanoma Stage IV, Melanoma, Uveal Trial in Rochester ([203Pb]VMT01, [68Ga]VMT02)

Recruiting
  • Melanoma (Skin)
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
Aug 5, 2022

Melanoma (Skin), Metastatic Melanoma, Melanoma Stage IV Trial in Iowa City, Rochester, Madison ([212Pb]VMT01)

Not yet recruiting
  • Melanoma (Skin)
  • +5 more
  • Iowa City, Iowa
  • +2 more
Dec 8, 2022

Recurrent Vulvovaginal Candidiasis Trial in United States (Oteseconazole (VT-1161) 150mg capsule, Fluconazole 150mg capsule,

Completed
Has Results
  • Recurrent Vulvovaginal Candidiasis
  • Oteseconazole (VT-1161) 150mg capsule
  • +2 more
  • Tucson, Arizona
  • +32 more
Feb 3, 2022

Uveitis Trial run by the CC (Microplasmin)

Terminated
Has Results
  • Uveitis
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 3, 2018

Tinea Pedis Trial in United States (VT-1161, )

Completed
Has Results
  • Tinea Pedis
  • Birmingham, Alabama
  • +6 more
Jul 5, 2018

Vitreomacular Adhesion Including Macular Hole Trial in United States (Ocriplasmin, Sham injection)

Completed
Has Results
  • Vitreomacular Adhesion Including Macular Hole
  • Phoenix, Arizona
  • +24 more
Feb 18, 2016

Vitreomacular Traction Trial in Belgium, Germany (ocriplasmin, Sham Comparator)

Completed
Has Results
  • Vitreomacular Traction
  • Antwerpen, Belgium
  • +3 more
Dec 2, 2014